During the past decade, Neurology Center of New England conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Neurology Center of New England" #1 sponsor was "EMD Serono Research & Development Institute, Inc." with 3 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "ACADIA Pharmaceuticals Inc." with 1 trials sponsored, "Amgen" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neurology Center of New England" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "Ipsen" with 1 trials as a collaborator and "Mallinckrodt ARD Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Neurology Center of New England" are "Multiple Sclerosis" (5 trials), "Multiple Sclerosis, Relapsing-Remitting" (3 trials), "Migraine" (2 trials), "Parkinson Disease" (1 trials) and "Parkinson Disease Psychosis" (1 trials). Many other conditions were trialed in "Neurology Center of New England" in a lesser frequency.

Most popular intervention types in "Neurology Center of New England" are "Drug" (7 trials), "Biological" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cladribine Tablets" (2 trials), "Ocrelizumab" (2 trials), "Placebo" (2 trials), "Abobotulinumtoxin A" (1 trials) and "Antihistamine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neurology Center of New England" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Neurology Center of New England". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Neurology Center of New England, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Neurology Center of New England, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".